Emerging peptide antibiotics with therapeutic potential.

Gregory Upert1, Anatol Luther2, Daniel Obrecht1

  • 1Polyphor Ltd, Hegenheimermattweg 125, 4123 Allschwil, Switzerland.

Summary

This review highlights recent advancements in peptide antibiotics, focusing on novel mechanisms and proven effectiveness in animal models. It explores various peptide types and their targets within bacterial cell membranes.

Keywords:
ADMET, absorption, distribution, metabolism and excretion – toxicity in pharmacokineticsAMP, antimicrobial peptideAMR, antimicrobial resistanceATCC, ATCC cell collectionAntibioticBAM, β-barrel assembly machineryCC50, cytotoxic concentration to kill 50% of cellsCD, circular dichroismCFU, colony forming unitCLSI, clinical and laboratory standards instituteCMS, colistin methane sulfonateDMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholineESKAPE, acronym encompassing six bacterial pathogens (often carrying antibiotic resistance): Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter sppFDA, U. S. Food and Drug AdministrationHABP, hospital acquired bacterial pneumoniaHDP, host-defense peptideHEK293, human embryonic kidney 293 cellsHK-2, human kidney 2 cells (proximal tubular cell line)HepG2, human hepatocellular carcinoma cell lineHpg, 4-hydroxy-phenyl glycineITC, isothermal titration calorimetryKPC, Klebsiella pneumoniae metallo-β-lactamase C resistantLPS, lipopolysaccharideLptA, lipopolysaccharide transport protein ALptC, lipopolysaccharide transport protein CLptD, lipopolysaccharide transport protein DMDR, multidrug-resistantMH-I, Müller-Hinton broth IMH-II, Müller-Hinton broth II (cation adjusted)MIC, minimal inhibitory concentrationMRSA, methicilline-resistant S. aureusMSSA, methicilline-sensitive S. aureusMoA, mechanism (mode) of actionNDM-1, New Delhi metallo-β-lactamase resistantNOAEL, no adverse effect levelODL, odilorhabdinOMPTA (outer membrane targeting antibiotic)OMPTA, outer membrane targeting antibioticOmp, outer membrane proteinPBMC, peripheral mononuclear blood cellPBP, penicillin-binding proteinPBS, phosphate-buffered salinePK, pharmacokineticsPOPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholinePOPG, 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-(1-glycerol)PrAMPs, polyproline antimicrobial peptidesRBC, red blood cellSAR, structure-activity relationshipSPR, surface plasmon resonanceSPase I, signal peptidase IVABP, ventilator associated bacterial pneumoniaVIM-1, beta-lactamase 2 (K. pneumoniae)VISA, vancomycin-intermediate S. aureusVRE, vancomycin-resistant enterococcusWHO, World Health OrganizationWT, wild typeWTA, wall teichoic acidXDR, extremely drug-resistantantimicrobial peptideantimicrobial resistancebid, bis in die (two times a day)i.p., intraperitoneali.v., intravenouslipopeptidemITT population, minimal intend-to-treat populationpeptide antibiotics.c., subcutaneous

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.4K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
676
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
818
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
264
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
1.2K